Warning: file_get_contents(http://tehnika-news.ru/shells.txt): failed to open stream: Connection refused in /var/sites/p/paperbomb.com/public_html/meds2/1/index.php on line 2
beta o2

beta o2

Перейти к контенту

Главное меню:

Разное
beta o2
Beta-O2 Technologies Ltd., Beta-O2 Technologies Ltd. | Clinical Trials, O2 Protect beta - O2 Community, iOS 4.1 Beta - O2 Community, Beta-O2 Receives Grant from JDRF to Advance Clinical , Tornado Insider - Radar company - Beta-O2, , , .
Phase I Safety/Efficacy StudyEight patients who meet the study criteria will be enrolled in a two-year, open label, pilot investigation which will evaluate the safety and efficacy of implanting the ßAir macro-encapsulation with human islets of Langerhans. Enrollment is nearly complete.The study is being conducted at Uppsala University Hospital in Sweden.The principal investigator is Dr. Per-Ola Carlsson, professor at the Department of Medical Cell Biology, and the Department of Medical Sciences, Uppsala University.Four patients have been implanted thus far with the βAir Bio-artificial Pancreas. The first patient in the study was implanted in October 2014. .The study is partially funded by a grant awarded to Beta-O2 by the JDRF in September 2014. . The βAir device contains living cells that sense the level of glucose and produce insulin and glucagon accordingly.. Phase I Safety/Efficacy Study. Eight patients who meet the study criteria will be enrolled in a two-year, open label, pilot investigation which will evaluate the safety and efficacy of implanting the ßAir macro-encapsulation with human islets of Langerhans..
O2 Protect Beta – keeping your digital stuff safe Hey Guys, We need your help with this beta trail. What is it? O2 Protect is a new digital service. We use cookies to help you get the best experience from our site and show you more relevant products. Carry on browsing without changing your settings if you agree to our use of cookies.. ROSH HA-AYIN, Israel, September 10, 2014 /PRNewswire/ -- Beta-O2 announced today that it has received a $500K grant from JDRF. The grant will be used to help. Beta-O2 develops technology to supply oxygen to transplanted cells. The first application of this technology will supply oxygen to islet cells, which are transplanted into diabetics who require insulin for day-to-day functioning.. . .
 
Copyright 2019. All rights reserved.
Назад к содержимому | Назад к главному меню